Life Sciences Health Industry China Briefing
This post was written by Jay Yan, Mao Rong, Zack Dong, Zhao Hong, and Gordon Schatz.
Reed Smith’s Life Sciences Health Industry China Briefing provides a summary of the monthly news and legal developments relating to China's Pharmaceutical, Medical Device, and Life Sciences/ Health Care Industries.
Some important developments during September include:
- SFDA Circulates Guidelines for Monitoring Adverse Events Involving Medical Devices
- SFDA Issues Letter Soliciting Public Comments on Communication Methods for Responsible Food and Drug Safety
- Swiss Drugmaker Novartis Expands in China
- China to Divide Emergency Patients into Four Classes for Medical Treatment
- China’s Biopharmaceutical Industry to Accelerate Internationalization
- MOH surveys Clinical Application of Antimicrobials
- Medtronic Opens Orthopedic R&D Center with Weigao
- DHL Establishes Second Life Science and Health Care Logistics Center in Beijing
To read the full briefing by Reed Smith China team members, click here.
